Keyphrases
At-risk Mental State
100%
Schizophrenia
99%
Psychosis
58%
First-episode Psychosis
42%
Clinical High Risk for Psychosis (CHR-P)
42%
Schizophrenic Patients
37%
Cognitive Function
33%
Patients with Schizophrenia
32%
Healthy Controls
26%
Individuals at Risk
25%
Socio-cognitive
20%
Rating Scales
17%
Social Functioning
14%
MRI Study
14%
Social Function
13%
High-risk Subjects
13%
Structural Magnetic Resonance Imaging (sMRI)
13%
Brief Assessment of Cognition in Schizophrenia
12%
Cognitive Impairment
12%
High Risk
12%
Mismatch Negativity
12%
Pituitary Volume
12%
Vulnerability
12%
Olfactory Function
10%
Japan
10%
Assessment Scale
9%
Functioning Assessment
9%
Occupational Functioning
9%
Psychotic Disorders
9%
Duration Mismatch
9%
Executive Function
9%
Symptom Severity
9%
Clinical Characteristics
8%
Pineal Gland Volume
8%
Chronic Schizophrenia
8%
Illness
8%
Magnetic Resonance Imaging Study
8%
Gyrification
8%
Antipsychotics
8%
Odor Identification
7%
Quality of Life
7%
Functional Outcome
7%
Clinical Setting
7%
Japanese Version
7%
Clinical Services
7%
Cortical Thickness
7%
Atrophy
6%
Patients at Risk
6%
Magnetic Resonance Imaging
6%
Cortical Distance
6%
Neuroscience
Cognitive Function
48%
Magnetic Resonance Imaging
35%
Cognitive Disorders
21%
Antipsychotic
21%
Typical Antipsychotic
15%
Gyri
15%
Mismatch Negativity
15%
Magnetic Resonance Imaging
14%
Negative Syndrome
14%
Longitudinal Study
13%
Psychosis
12%
Pineal Gland
12%
Gyrification
11%
Schizophrenia
10%
Hyperactivity
10%
Positive Syndrome
9%
Event-Related Potential
9%
Pituitary Gland
8%
Gray Matter Volume
8%
Gray Matter
7%
Olfactometer
6%
Executive Function
6%
Paracentral Lobule
6%
Early Psychosis
6%
Cannabis
6%
Planum Temporale
6%
Globus pallidus
6%
Clinical Guideline
6%
Orbitofrontal Cortex
6%
Olfaction
6%
Cognitive Behavioral Therapy
6%
Depression
6%
Thalamus
6%
Striatum
6%
Ventral Lateral Nucleus
6%
Olfactory System
6%
Psychotomimetic
6%
Trait Anxiety
5%